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Synchronous Occurrence of Papillary Carcinoma in the
Thyroid Gland and Thyroglossal Duct in an Adolescent
with Congenital Hypothyroidism 
Case Report
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In tro duc ti on
Differentiated thyroid carcinoma (TC) represents 0.4%-3%
of all childhood malignancies (1). The development of TC
combined with congenital hypothyroidism is a rare situation
(2,3). A few cases of TC arising from congenital goitre . have
been reported until now (4,5,6). 
An ectopic thyroid gland in a thyroglossal duct remnant
may be present in infants with congenital hypothyroidism (7).
Another developmental anomaly which can present with
congenital hypothyroidism is a thyroglossal duct cyst.
Approximately 1% of all thyroglossal duct cysts lead to TC, but
synchronous development of thyroglossal cyst carcinoma and
TC is extremely rare (8,9,10). 
In this report, we describe a patient presenting with
congenital hypothyroidism in the neonatal period and who
subsequently developed synchronous thyroglossal cyst
carcinoma and TC.  
Case Report 
A 13-day-old male infant presented to our clinic with  goitre
and hypoactivity. He was the first child of parents who were first-
degree relatives. The father had undergone thyroidectomy 
for multinodular goitre. A state of primary congenital
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Thyroid carcinoma (TC) combined with congenital hypothyroidism is rare.
The synchronous occurrence of these two conditions is even rarer. We
describe a patient with congenital hypothyroidism in whom
hyperthyroglobulinemia and nodules developed despite adequate
replacement therapy. Papillary TC was detected at age 19 years.
Postoperative diagnostic scintigraphy showed increased uptake in the
thyroglossal duct region. Repetitive imaging of the thyroid gland can be
useful in the early detection of TC in patients with congenital
hypothyroidism. Moreover, this rare situation can be complicated by a
synchronous thyroglossal duct carcinoma. Thyroglossal duct carcinoma
can be detected if diagnostic scintigraphy is performed after total
thyroidectomy. 
Key words: Congenital, hypothyroidism, differentiated thyroid carcinoma,
synchronous, thyroglossal duct carcinoma 
Conflict of interest: None declared
Re cei ved: 05.09.2011 Ac  cep ted: 24.10.201131
Şıklar Z et al.
Synchronous Thyroid Papillary Carcinoma
hypothyroidism was detected in our patient. His total thyroxine
(T4) level was 1.6 μg/dL (N: 4.5-12), his total triiodothyronine
level (T3) 0.6 ng/mL (N: 0.55-2.5), and his thyrotropin (TSH) level
was 84 mIU/mL (N:0.5-5). T4 replacement therapy was initiated.
In the first 3 years of follow-up, despite treatment and normal
growth and development pattern, the patient continued to have
persistently high TSH levels (mean TSH: 13 mIU/mL), despite
upper-normal levels of free T4 (fT4). These high levels persisted
for almost 9 years, but gradually decreased afterwards. At age
9 years, TSH: level was 3 mIU/mL. fT4, free T3 (fT3) and TSH
levels remained within normal limits thereafter (Table 1).  
When he was 13.4 years of age, the patient developed a
goitre and hyperthyroglobulinemia. Thyroid ultrasound
demonstrated a 4-mm solid nodule in the right lobe. Fine-
needle aspiration (FNA) biopsy did not reveal any pathology.
Thyroid scintigraphy showed a diffuse hyperplastic thyroid
gland (Figure 1). Thyroid autoantibodies were negative and
urinary iodine level was normal. 
During follow-up, an increase in thyroid volume,
hyperthyroglobulinemia (with fluctuating levels reaching up to
1100 ng/mL), and new nodule formation were noted. A second
FNA biopsy performed at age 16 years showed no malignancy.
One year later, upon detection of a cold nodule measuring 9mm
in diameter in the right lobe, a right lobectomy was performed.
Histological examination revealed follicular adenoma. Following
the right lobectomy, thyroglobulin (Tg) levels showed a
decrease initially, but started to increase one year later together
with a gradual increase in the size of nodules in the left lobe,
which led to a decision for total thyroidectomy with central neck
lymph node dissection. Histological examination revealed
findings compatible with follicular variant of papillary TC;  tumor
size was 6 mm. 
Although not detected on preoperative scintigraphy,
postoperative diagnostic scintigraphy with low dose of I-131
(2 mCi) showed increased uptake in the thyroglossal region
(Figure 2). Surgical exploration for thyroglossal remnants
revealed a presence of a follicular variant of papillary TC which
had developed synchronously. Levothyroxine (LT4)
replacement therapy and radioiodine ablation of the possible
remnant thyroid tissue were started. At this time, we learnt
that the patient’s sister had been diagnosed as a case of
euthyroid diffuse goitre and that she also had developed a
follicular adenoma in the follow-up.
Discussi on
The case presented here had goitrous congenital
hypothyroidism and developed TC in his adolescent years. Only
a few cases of TC arising from dyshormonogenetic goitre of the
thyroid gland have been reported to date (11,12). In our patient,
despite adequate replacement therapy, the TSH level had not
been suppressed completely until he was 9 years old. High TSH
levels are believed to induce the thyroid gland, leading to
changes such as nodule formation. It has been suggested that
constant and prolonged stimulation by TSH may lead to
Fi gu re  1. Thyroid scintigraphy before diagnosis of thyroid carcinoma Fi gu re  2.  Low-dose I-131 scintigraphy after thyroidectomy
Tab le  1. Mean LT4 doses and mean TSH, fT4, fT3 levels of the patient during follow-up
LT4 dose (µg/kg/day)  TSH (mIU/mL) fT3 (pmol/L) (N:3-6.8) fT4 (pmol/L) (N:10-22) Tg (ng/mL) (N:10-30) 
0-3 years  5.24  13.60 9.37 21.90  NA 
3-9 years 3.68 6.30 7.36 18.00 NA
10-17 years  2.57 3.77 7.24 17.40 50.80
>17 years 2.06 2.12 6.80 22.30 88.05
TSH: thyrotropin, fT4: free thyroxine, fT3: free triiodothyronine, LT4: levothyroxine, Tg: thyroglobulin, NA: not available32
occurrence of malignant thyroid cells (2). It has also been
suggested that combined with dyshormonogenetic congenital
hypothyroidism, ineffective treatment of congenital
hypothyroidism and occurrence of high TSH levels from time to
time may be responsible for pathophysiological mechanisms
leading to the development of TC (11). Malignant
transformation can occur if elevated TSH levels are sustained
for a prolonged period of time (2).   
Our patient was compliant to therapy, with almost no
reported instances of missed LT4 dose. In the first years of
LT4 therapy, high-normal fT4 levels were accompanied by
mild TSH increments, a finding resembling a state of mild
resistance to TSH suppression.  The patient developed  TC 10
years after the normalization of TSH levels. Thus, we suggest
that the high TSH levels noted in the patient’s first 9 years of
life could have contributed to TC development at age 19
years. We believe that the high TSH levels appear to be a
probable etiological factor for TC in this patient. 
There was also a tendency to formation of thyroid nodules
in our patient’s family.  Some genetic defects are known to
facilitate carcinoma development in patients with congenital
hypothyroidism.  It was reported that metastatic TC can arise
from congenital goitre due to Tg or thyroperoxidase gene
mutations (2,5). We were not able to investigate thyroid-
associated gene mutations in this patient. However, unlike the
findings in our patient, almost no Tg is detected in patients
with Tg gene mutations. Fluctuating increased Tg levels found
in our patient warn us about the possibility of elevated Tg
levels being a key factor for TC development. 
In our patient, following the surgical intervention to the
thyroid gland, a low-dose radioiodine scanning showed
minimal uptake in the thyroid bed, but increased uptake in the
thyroglossal duct region. Interestingly, this region could not be
visualized scintigraphically before thyroidectomy. 
Iodine ablation after thyroidectomy and postablative
whole-body scintigraphy are important components of the
management of TC in children and adolescents. Before high-
dose radioiodine ablation, one should be sure that no extra
thyroidal tissue is left. The success of radioiodine ablation
depends on the amount of thyroid tissue. If the amount of
remnant tissue is high, most of the radioiodine dose will be
trapped by this tissue and the effectiveness of ablation will be
decreased. Also, distant metastases cannot be detected. If
radioiodine ablation is applied before performing diagnostic
low-dose I-131 scintigraphy, almost all of the ablation dose
will be trapped by thyroglossal duct remnants and it will not
be possible to detect presence of distant metastases.
In this patient, we detected synchronous development of
differentiated papillary carcinoma in the thyroid gland and
thyroglossal duct. First, thyroid gland carcinoma, and
subsequently thyroglossal duct carcinoma were diagnosed.
Functional follicular thyroid cells can be found in thyroglossal
duct remnants (7). TC can arise in thyroglossal duct cysts
rarely, with fewer than 200 cases reported. The incidence was
reported as 1.3% of all thyroglossal duct cysts. About 1% of
patients with thyroglossal duct cysts were treated for papillary
TC arising in thyroglossal duct cysts (12), and in most of these
patients, TC was diagnosed in the fourth decade of life (13).
The largest series was reported from France, including 18
cases aged from 27 to 68 years (12). In children, TC
originating from thyroglossal cyst has been reported in fewer
than ten cases (13,14). However, the synchronous occurrence
of TC and thyroglossal duct carcinoma is reported to be
extremely rare (13). More than half of the patients in these
series showed concomitant microcarcinoma (most of them
smaller than 1 mm in diameter) in the thyroid gland (12). 
The findings in our patient point out the importance of
investigating the possible presence of TC in patients with
thyroglossal duct carcinoma, and vice versa. 
In conclusion, we would like to stress the importance of
repetitive imaging of the thyroid gland in patients with
congenital hypothyroidism, especially in those with high Tg
levels and nodule formation. Thyroglossal duct carcinoma can
develop in patients with congenital hypothyroidism.
Moreover, this rare situation can be complicated by
synchronous TC. Thyroglossal duct carcinoma can remain
undiagnosed if diagnostic I-131 scintigraphy is not done after
total thyroidectomy. 
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